ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Faricimab in Participants With Macular Edema Secondary to Branch Retinal Vein Occlusion

ClinicalTrials.gov ID: NCT04740905

Public ClinicalTrials.gov record NCT04740905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 5, 2026, 12:51 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double-Masked, Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of Faricimab in Patients With Macular Edema Secondary to Branch Retinal Vein Occlusion

Study identification

NCT ID
NCT04740905
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Hoffmann-La Roche
Industry
Enrollment
553 participants

Conditions and interventions

Interventions

  • Aflibercept Drug
  • Faricimab Drug
  • Sham Procedure Procedure

Drug · Procedure

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 1, 2021
Primary completion
Jul 5, 2022
Completion
Jun 11, 2023
Last update posted
Aug 5, 2024

2021 – 2023

United States locations

U.S. sites
39
U.S. states
22
U.S. cities
39
Facility City State ZIP Site status
Retinal Research Institute, LLC Phoenix Arizona 85014
Retina Associates Southwest PC Tucson Arizona 85704
Retinal Diagnostic Center Campbell California 95008
The Retina Partners Encino California 91436
California Eye Specialists Medical group Inc. Pasadena California 91107
Retina Consultants, San Diego Poway California 92064
Retina Consultants of Southern Colorado PC Colorado Springs Colorado 80909
Retina Group of New England Waterford Connecticut 06385
Florida Eye Associates Melbourne Florida 32901
Fort Lauderdale Eye Institute Plantation Florida 33324
Retina Vitreous Assoc of FL St. Petersburg Florida 33711
Southern Vitreoretinal Assoc Tallahassee Florida 32308
Retina Associates of Florida, LLC Tampa Florida 33609
Southeast Retina Center Augusta Georgia 30909
Georgia Retina PC Marietta Georgia 30060-1137
Retina Consultants of Hawaii ‘Aiea Hawaii 96701
University Retina and Macula Associates, PC Oak Forest Illinois 60452
Prairie Retina Center Springfield Illinois 62704
Cumberland Valley Retina PC Hagerstown Maryland 21740
Tufts Medical Center; Ophthalmology Boston Massachusetts 02111
Assoc Retinal Consultants PC Royal Oak Michigan 48073
VitreoRetinal Surgery, PLLC.; DBA Retina Consultants of Minnesota Edina Minnesota 55435
Midwest Vision Research Foundation Chesterfield Missouri 63017
Sierra Eye Associates Reno Nevada 89502
Retina Associates of NJ Teaneck New Jersey 07666
Long Is. Vitreoretinal Consult Hauppauge New York 11788
Retina Vit Surgeons/Central NY Liverpool New York 13088
Graystone Eye Hickory North Carolina 28602
Cincinnati Eye Institute Cincinnati Ohio 45242
Black Hills Eye Institute Rapid City South Dakota 57701
Charles Retina Institute Germantown Tennessee 38138
Tennessee Retina PC Nashville Tennessee 37203
Retina Res Institute of Texas Abilene Texas 79606
Austin Retina Associates Austin Texas 78705-1169
Retina & Vitreous of Texas Bellaire Texas 77401-3510
Texas Retina Associates Dallas Texas 75231
Retina Consultants of Texas The Woodlands Texas 77384-4167
Strategic Clinical Research Group, LLC Willow Park Texas 76087
Retina Associates of Utah, PLLC Salt Lake City Utah 84107

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 111 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04740905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 5, 2024 · Synced May 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04740905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →